This website is intended for healthcare professionals

New government initiative to reduce cost of HRT for menopausal women

On the 21 February 2023, it was announced that the UK government would start subsidising the price of hormone replacement therapy (HRT), with around 400 000 women in England potentially benefiting...

Updates

The UK government has announced a new initiative to make hormone replacement therapy (HRT) more affordable for women experiencing symptoms of menopause. The move is expected to benefit hundreds of...

Drug Breakdown: Carbimazole

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate .

Research to support diabetes remission in general practice

Diabetes UK (2023), together with the American Diabetes Association and the European Association for the Study of Diabetes, defines remission as HbA1c levels remaining below 48 mmol/mol or 6.5% for...

Alzheimer’s disease, amyloid and ethics

In November 2022, van Dyck et al (2022) reported the results of an 18-month, double-blind, phase 3 trial of 1795 participants with early Alzheimer’s disease and evidence of amyloid. Half received...

When was the last time you held an FP10 prescription in hand?

A visit to my GP recently, which required a prescription, led me to ask myself: when was the last time I held a paper FP10 green prescription in my hand? As someone with a long-term condition...

Updates

NICE has recommended a weekly injection for treating growth failure in children. The recommended treatment, known as growth hormone therapy, involves a weekly injection of a hormone called somatropin....

Drug Breakdown: Sitagliptin

Day 1: In the 1990s, growing insight into incretin roles in type 2 (T2DM) diabetes led to an interest in the breakdown of gut hormone GLP-1. DPP-4 was identified as the best peptidase target and a...

Treating chronic obstructive pulmonary disease in people with type 2 diabetes

A new study published in the British Medical Journal has examined whether the use of the receptor agonist glucagon-like peptide 1 (GLP-1), dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose...

Adverse drug reactions

This piece of original research published in July 2022 aimed to elucidate the burden and associated cost of ADRs, polypharmacy and multimorbidity with a prospective analysis of all medical admissions...

Enzalutamide in the treatment of metastatic castrate-sensitive prostate cancer

Enzalutamide is an orally administered, small-molecule inhibitor of the androgen receptors and is designed to overcome acquired resistance to first-generation nonsteroidal antiandrogens, including...

The role of the designated prescribing supervisor: an evaluation

There were four main themes identified from the semi-structured interviews. These were cross-referenced against the qualitative responses from the initial investigative survey and were seen to align...

Assessing and managing wound pain

Pain assessment should form part of the initial wound assessment, and there are many pain tools available. Nemeth et al (2003) reviewed the five most commonly used tools for measuring leg ulcer pain,...

Side effects of decongestants in cold and flu season

As we make our way through cold and flu season, prescribers are likely to encounter many patients with varying degrees of illness from these viruses..

Prescribing in the homeless population

This article, published in the International Journal of Clinical Pharmacy aimed to investigate the prescribing of medicines to homeless persons who present to specialist homelessness primary care...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP